297 related articles for article (PubMed ID: 28416489)
1. NRF2 Induction Supporting Breast Cancer Cell Survival Is Enabled by Oxidative Stress-Induced DPP3-KEAP1 Interaction.
Lu K; Alcivar AL; Ma J; Foo TK; Zywea S; Mahdi A; Huo Y; Kensler TW; Gatza ML; Xia B
Cancer Res; 2017 Jun; 77(11):2881-2892. PubMed ID: 28416489
[TBL] [Abstract][Full Text] [Related]
2. Dipeptidyl-peptidase 3 protects oxygen-glucose deprivation/reoxygenation-injured hippocampal neurons by suppressing apoptosis, oxidative stress and inflammation via modulation of Keap1/Nrf2 signaling.
Ren X; Yu J; Guo L; Ma H
Int Immunopharmacol; 2021 Jul; 96():107595. PubMed ID: 33812256
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of ubiquitin ligase KEAP1 reveals associated proteins that inhibit NRF2 ubiquitination.
Hast BE; Goldfarb D; Mulvaney KM; Hast MA; Siesser PF; Yan F; Hayes DN; Major MB
Cancer Res; 2013 Apr; 73(7):2199-210. PubMed ID: 23382044
[TBL] [Abstract][Full Text] [Related]
4. Acute expression of the transcription factor Nrf2 after treatment with quinolinic acid is not induced by oxidative stress in the rat striatum.
Silva-Islas CA; Chánez-Cárdenas ME; Barrera-Oviedo D; Ibarra-Rubio ME; Maldonado PD
Neurotoxicology; 2019 Jul; 73():120-131. PubMed ID: 30876764
[TBL] [Abstract][Full Text] [Related]
5. Dipeptidyl peptidase 3 is essential for maintaining osteoblastic differentiation under a high-glucose environment by inhibiting apoptosis, oxidative stress and inflammation through the modulation of the Keap1-Nrf2 pathway.
Li X; Yu X; He S; Li J
Int Immunopharmacol; 2023 Jul; 120():110404. PubMed ID: 37276831
[TBL] [Abstract][Full Text] [Related]
6. Expression of xCT and activity of system xc(-) are regulated by NRF2 in human breast cancer cells in response to oxidative stress.
Habib E; Linher-Melville K; Lin HX; Singh G
Redox Biol; 2015 Aug; 5():33-42. PubMed ID: 25827424
[TBL] [Abstract][Full Text] [Related]
7. Absence of Dipeptidyl Peptidase 3 Increases Oxidative Stress and Causes Bone Loss.
Menale C; Robinson LJ; Palagano E; Rigoni R; Erreni M; Almarza AJ; Strina D; Mantero S; Lizier M; Forlino A; Besio R; Monari M; Vezzoni P; Cassani B; Blair HC; Villa A; Sobacchi C
J Bone Miner Res; 2019 Nov; 34(11):2133-2148. PubMed ID: 31295380
[TBL] [Abstract][Full Text] [Related]
8. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
Namani A; Matiur Rahaman M; Chen M; Tang X
BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
[TBL] [Abstract][Full Text] [Related]
9. The oncoprotein HBXIP competitively binds KEAP1 to activate NRF2 and enhance breast cancer cell growth and metastasis.
Zhou XL; Zhu CY; Wu ZG; Guo X; Zou W
Oncogene; 2019 May; 38(21):4028-4046. PubMed ID: 30692632
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of Keap1-Nrf2 protein-protein interaction reduce estrogen responsive gene expression and oxidative stress in estrogen receptor-positive breast cancer.
Xie T; Zahid H; Ali AR; Joyce R; Yang G; Winz C; Le Y; Zhou R; Furmanski P; Hu L; Suh N
Toxicol Appl Pharmacol; 2023 Feb; 460():116375. PubMed ID: 36634873
[TBL] [Abstract][Full Text] [Related]
11. DPP9 Stabilizes NRF2 to Suppress Ferroptosis and Induce Sorafenib Resistance in Clear Cell Renal Cell Carcinoma.
Chang K; Chen Y; Zhang X; Zhang W; Xu N; Zeng B; Wang Y; Feng T; Dai B; Xu F; Ye D; Wang C
Cancer Res; 2023 Dec; 83(23):3940-3955. PubMed ID: 37713596
[TBL] [Abstract][Full Text] [Related]
12. Binding of dipeptidyl peptidase III to the oxidative stress cell sensor Kelch-like ECH-associated protein 1 is a two-step process.
Matić S; Kekez I; Tomin M; Bogár F; Šupljika F; Kazazić S; Hanić M; Jha S; Brkić H; Bourgeois B; Madl T; Gruber K; Macheroux P; Matković-Čalogović D; Matovina M; Tomić S
J Biomol Struct Dyn; 2021 Nov; 39(18):6870-6881. PubMed ID: 32811353
[TBL] [Abstract][Full Text] [Related]
13. Metformin diminishes the unfavourable impact of Nrf2 in breast cancer patients with type 2 diabetes.
Urpilainen E; Kangaskokko J; Puistola U; Karihtala P
Tumour Biol; 2019 Jan; 41(1):1010428318815413. PubMed ID: 30803422
[TBL] [Abstract][Full Text] [Related]
14. A Naturally-Occurring Dominant-Negative Inhibitor of Keap1 Competitively against Its Negative Regulation of Nrf2.
Qiu L; Wang M; Zhu Y; Xiang Y; Zhang Y
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30042301
[TBL] [Abstract][Full Text] [Related]
15. The emerging role of dipeptidyl peptidase 3 in pathophysiology.
Malovan G; Hierzberger B; Suraci S; Schaefer M; Santos K; Jha S; Macheroux P
FEBS J; 2023 May; 290(9):2246-2262. PubMed ID: 35278345
[TBL] [Abstract][Full Text] [Related]
16. Interdisciplinary Study of the Effects of Dipeptidyl-Peptidase III Cancer Mutations on the KEAP1-NRF2 Signaling Pathway.
Matić S; Tomašić Paić A; Sobočanec S; Pinterić M; Pipalović G; Martinčić M; Matovina M; Tomić S
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216111
[TBL] [Abstract][Full Text] [Related]
17. The Keap1-Nrf2 Stress Response Pathway Promotes Mitochondrial Hyperfusion Through Degradation of the Mitochondrial Fission Protein Drp1.
Sabouny R; Fraunberger E; Geoffrion M; Ng AC; Baird SD; Screaton RA; Milne R; McBride HM; Shutt TE
Antioxid Redox Signal; 2017 Dec; 27(18):1447-1459. PubMed ID: 28494652
[TBL] [Abstract][Full Text] [Related]
18.
Akdemir B; Nakajima Y; Inazawa J; Inoue J
Mol Cancer Res; 2017 Nov; 15(11):1570-1578. PubMed ID: 28760781
[TBL] [Abstract][Full Text] [Related]
19. Canonical and non-canonical mechanisms of Nrf2 activation.
Silva-Islas CA; Maldonado PD
Pharmacol Res; 2018 Aug; 134():92-99. PubMed ID: 29913224
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution.
Taguchi K; Motohashi H; Yamamoto M
Genes Cells; 2011 Feb; 16(2):123-40. PubMed ID: 21251164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
